Ridgemont Equity Partners, a private equity firm, has acquired American Outcomes Management, a specialty infusion provider. The financial terms of the transaction were not disclosed.

American Outcomes Management provides home-based IVIG therapy to patients with over 80 different chronic conditions and provides support services, including pharmacy services.

“AOM has a tremendous growth opportunity ahead and several avenues for expansion,” said AOM’s Chairman Chris York. “Our vision for the business starts with investing in our team and capabilities to expand our presence in all geographic markets and offer additional specialty infusion therapies.”

Financing for the transaction was provided by AB Private Credit Investors and BMO Sponsor Finance. Houlihan Lokey Capital served as financial advisor to Ridgemont.